Everolimus drug‐eluting stent performance in patients with long coronary lesions: The multicenter Longprime registry-Reference-Cited by-同舟云学术

Everolimus drug‐eluting stent performance in patients with long coronary lesions: The multicenter Longprime registry

Published:2018-05-18 Issue:7 Volume:92 Page:E493-E501
ISSN:1522-1946
Container-title:Catheterization and Cardiovascular Interventions
language:en
Short-container-title:Catheter Cardiovasc Interv

Author:

Díaz Fernández José Francisco¹,Camacho Freire Santiago Jesús¹^ORCID,Fernández Guerrero Juan Carlos²,Delarche Nicolas³,Bretelle Christophe⁴,Zueco Gil Javier⁵,Palop Ramón López⁶,García del Blanco Bruno⁷,Mainar Tello Vicente⁸,Albert Franck⁹

Affiliation:

1. Department of CardiologyJuan Ramón Jiménez HospitalHuelva Spain

2. Department of CardiologyHospital General de JaenJaen Spain

3. Department of CardiologyCentre Hospitalier Francois MitterandPau France

4. Department of CardiologyCentre Hospitalier de ValenceValence France

5. Department of CardiologyMarques de Valdecilla HospitalSantander Spain

6. Department of CardiologySan Juan de Alicante HospitalAlicante Spain

7. Department of CardiologyValle de Hebron HospitalBarcelona Spain

8. Department of CardiologyHospital General Universitario de AlicanteAlicante Spain

9. Department of CardiologyCentre Hospitalier de ChartresChartres France

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,Radiology Nuclear Medicine and imaging,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ccd.27657

Reference32 articles.

1. Efficacy and safety of FIREHAWK abluminal groovelled biodegradable polymer sirolimus‐eluting stents for the treatment of long coronary lesions: Nine‐month angiographic and one‐year clinical results from TARGET I trial long cohort;Xu B;Chin Med J (Engl),2013

2. Comparison of Resolute Zotarolimus-Eluting Stents and Sirolimus-Eluting Stents in Patients With De Novo Long Coronary Artery Lesions

3. Stent thrombosis and restenosis: what have we learned and where are we going? The Andreas Grüntzig Lecture ESC 2014

4. The Relationship and Threshold of Stent Length With Regard to Risk of Stent Thrombosis After Drug-Eluting Stent Implantation

5. Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-Term Safety and Performance of BioMime™ Morph Sirolimus-Eluting Coronary Stent System for Very Long Coronary Lesions;Cardiology Research;2024-06

2. Second-generation everolimus-eluting intracoronary stents: a comprehensive review of the clinical evidence;Future Cardiology;2024-01-31

3. Clinical research of drug-coated balloon after rotational atherectomy for severe coronary artery calcification;BMC Cardiovascular Disorders;2023-01-21

4. Impact of ultra-long sirolimus-eluting stents on coronary artery lesions: one-year results of real-world FLEX-LONG Study;Minerva Medica;2020-12

5. Safety and performance of everolimus-eluting stents comprising of biodegradable polymers with ultrathin stent platforms;Minerva Medica;2020-10